Skip to main content

Benfluorex and Lipid Metabolism

  • Chapter
Lipid Metabolism and Its Pathology

Abstract

In the western countries it is often observed the association of obesity with hyperglyceridemia, hyperuricemy and decreased glucose tolerance, described by Crepaldi as the Plurimetabolic syndrome. In this situation there are an accumulation of several risk factors in the same subject.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1985 Plenum Press, New York

About this chapter

Cite this chapter

Mesquita, M.F., Paiva de Carvalho, M.G., Rodrigues, P.O., Magalhães, J., de Matos, D., Halpern, M.J. (1985). Benfluorex and Lipid Metabolism. In: Halpern, M.J. (eds) Lipid Metabolism and Its Pathology. Springer, Boston, MA. https://doi.org/10.1007/978-1-4613-2445-4_17

Download citation

  • DOI: https://doi.org/10.1007/978-1-4613-2445-4_17

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4612-9486-3

  • Online ISBN: 978-1-4613-2445-4

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics